Americans for Safe Access
  • Issues
    Cannabis Therapeutics Cannabis Product Safety Patient Rights & Protections The Patient's Bill of Rights Cannabis Scheduling & YOU! Personal Home Cultivation Cannabis & Healthcare FAQ
  • Learn
    Patient Guides ASA Reports Travel Guide for Patients Advocate Resource Center The History of Cannabis In the United States ASA National Conferences
  • Get Involved
    ASA Campaigns Volunteer with ASA Working with ASA Take Action!
  • Laws
  • Blog
Donate

Blog

I Found a Vape Pen at My Son’s School. Finding Out What Was Inside Was a Lot Harder.

| September 14, 2023

By Doug Henry for Mother Jones One seller claims Gold Coast Clear is “working hard to keep their customers safe,” and that “these verified cartridges have undergone various lab tests approved by CannaSafe.” Of course, that language doesn’t say they...

Read more

SCHEDULE III Fears, Facts & the Future

Steph Sherer | September 13, 2023

Navigating Medical Cannabis in the Federal Arena The news of Health and Human Services’ (HHS) recommendation to move Cannabis to a Schedule III status created a flurry of media coverage and press statements from various cannabis stakeholders and elected officials...

Read more

Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III

| September 01, 2023

By Madeline Colli, Erin McEvoy for Cannabis Science and Technology On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way...

Read more

FDA JUST UNLOCKED A DOOR FOR CANNABIS POLICY, WILL CONGRESS PUSH IT OPEN?

Steph Sherer | August 31, 2023

What just Happened On Wednesday, Bloomberg news reported that Health and Human Services (HHS) is recommending that cannabis be rescheduled to Schedule III following the Food and Drug Administration’s (FDA) scientific review of cannabis under the direction of President Biden....

Read more

Prioritize Consumer Safety: Our response to a Congressional Request for Information on Federal Cannabinoid Hemp Regulation

Steph Sherer | August 22, 2023

Last week, Americans for Safe Access responded to a bicameral Congressional Request for Information on cannabinoid hemp regulation from the U.S. House Committee on Energy & Commerce and the U.S. Senate Committee on Health, Education, Labor, and Pensions.

Read more

Want to work in Maryland’s cannabis industry? There are classes and degrees for that.

| August 18, 2023

By Meredith Cohn for The Baltimore Banner “Most other programs around the country, as far as I know, are focused on professional skill development for working in the cannabis industry, but not so much on cannabis as a medicine. I...

Read more

Marijuana Groups Push Regulators To Adopt Universal Label For Cannabis Products To Facilitate Interstate Commerce And Promote Safety

Kyle Jaeger | August 18, 2023

By Kyle Jaeger for Marijuana Moment A coalition of marijuana reform organizations are calling on regulators across the world to adopt a universal symbol for marijuana products in the interest of promoting safety in the evolving cannabis market and making...

Read more

WHILE CONGRESS IS TAKING THEIR AUGUST RECESS, LET’S RESET OUR COMMITMENT TO MEDICAL CANNABIS ADVOCACY

Steph Sherer | August 14, 2023

Let’s be honest, medical cannabis is not the most pressing issue in Washington these days. I have experienced firsthand from walking the halls of Congress, that while a majority of members are sympathetic to the needs of patients, most do...

Read more

Opinion: States are scrambling to regulate cannabis. Federal regulations would ensure safe access.

Shelby Huffaker | August 11, 2023

By Shelby Huffaker for The San Diego Union Tribune In the United States, we are fortunate to have a robust regulatory system for ensuring medications — particularly those intended for consumption by individuals with pre-existing medical conditions — are held...

Read more

Emergency Motion Filed to Halt New Aspergillus Testing Requirements for Oregon Cannabis

Erin McEvoy | August 03, 2023

By Erin McEvoy for Cannabis Science and Technology “In addition to sinus and lung infections, people who have weakened immune systems, including those who have recently undergone surgery, may also be susceptible to chronic pulmonary aspergillosis, which is a progressive...

Read more
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 286
  • 287
  • >
Button reading 'The Truth About Medical Cannabis'

Share this page

Facebook Twitter LinkedIn

Sign up!

Get important updates on federal and state developments, what's happening with ASA, and inspiring stories of local activists giving you the news you need to stay informed and be an effective advocate.


Our Partners and Sponsors

Dr. Bronner's Magic Soaps logo
US Pain Foundation logo
American Herbal Products Association (AHPA) logo
International Cannabis Bar Association (INCBA) logo
American Cannabis Nurses Association logo
Society of Cannabis Clinicians logo
Veterans Initiative logo
Farmer Freeman logo
Realm of Caring logo
Nectar logo
International Society of Cannabis Pharmacists logo
Crown logo
Orrick logo
LESS+MORE logo
3C Cannabis Consulting logo
Bennabis Health logo
High Point Jewelry logo
CMED logo
Asian Cannabis Roundtable logo
Minority Cannabis Business Association logo
CBCB logo
Kanha logo
A2LA logo
A Therapeutic Alternative logo
The Cannabis Community logo
American Chemical Society logo
International Medical Cannabis Patient Coalition logo
Nova Analytic Labs logo
Wana Brands logo
Marijuana Clones Online logo
New Cannabis Ventures logo
SnapSlide logo
Prev Next

ASA serves our mission with the help and support of many organizations and businesses. Click here to learn more about these amazing allies!

The Future of Medical Cannabis is Up To Us!

Help us integrate cannabis treatments into US healthcare systems, ensuring safe access for all!

Donate Now!

About

  • ASA’s Accomplishments
  • Meet ASA’s Sponsors & Partners
  • Programs & Projects
  • Job & Internship Opportunities
  • ASA's Leadership
  • Working with ASA

Issues

  • Cannabis Therapeutics
  • Cannabis Product Safety
  • Patient Rights & Protections
  • The Patient's Bill of Rights
  • Cannabis Scheduling & YOU!
  • Personal Home Cultivation
  • Cannabis & Healthcare
  • FAQ

Pressroom

  • Request an Interview
  • Press List Signup
  • Press Releases

POLICY REPORTS

GUIDES FOR MEDICAL USE OF CANNABIS

Events

  • Webinars

Patient Focused Certification

  • Cannabis Workforce Training
  • Cannabis Business Support
  • Application Assistance
  • Product Safety Certification
  • Audit Preparedness

Cannabis Care Certification

  • Patient and Caregiver Education

Stakeholder Resources

  • Patients & Consumers
  • Advocates
  • Medical Professionals
  • Policymakers
  • Cannabis Businesses

Contact Us

  • 202.857.4272
  • [email protected]
  • 1629 K St NW #300,
    Washington, DC 20006
Logo
Sign in with Facebook or Email.
© Copyright 2024 | Privacy Policy & Website Disclaimers
Created with NationBuilder